Latest filing published 04 Dec 2020 for Y-mAbs Therapeutics, Inc., €1.7M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Pedro Claus Juan Moller-San: trading record in brief
Pedro Claus Juan Moller-San appears in our data through filings on Y-mAbs Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 5 filings, for trades running from 17 March 2020 to 3 December 2020.
Both buying and selling appear: 1 purchase worth €29k, against 4 sales worth €8.9M. Sales outweigh purchases by €8.9M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The latest filing, published on 4 December 2020, reports an open-market sale of €1.7M in Y-mAbs Therapeutics, Inc. The last insider purchase was made public on 19 March 2020, 2,426 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Pedro Claus Juan Moller-San
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 40,734 shares@ US$51.265419.5% of flowCommon StockSEC:0001104659-20-132165:0
- 9,266 shares@ US$50.97964.4% of flowCommon StockSEC:0001104659-20-132165:1
- 60,846 shares@ US$37.7523.8% of flowCommon StockSEC:0001104659-20-062625:0
- 139,154 shares@ US$36.0252.1% of flowCommon StockSEC:0001104659-20-062625:1
- 1,900 shares@ US$17.220.3% of flowCommon StockSEC:0001104659-20-035949:0Canonical exit: 15 Jun 2020 (T+90)
5 of 5 declarations